- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.69 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 10 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
G39.4: 13 residues within 4Å:- Chain A: R.37, E.38, D.70, R.71, W.98, R.144, N.166, E.196, E.197, R.212, N.214, R.287, Y.321
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:W.98, A:N.166, A:E.196
- Hydrogen bonds: A:E.38, A:R.71
- Water bridges: A:D.70, A:D.70, A:R.71, A:R.75, A:E.197, A:R.212
- Salt bridges: A:R.37, A:R.212, A:R.287
G39.15: 13 residues within 4Å:- Chain B: R.37, E.38, D.70, R.71, W.98, R.144, N.166, E.196, E.197, R.212, N.214, R.287, Y.321
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:W.98, B:N.166, B:E.196
- Hydrogen bonds: B:E.38, B:R.71, B:Y.321
- Water bridges: B:R.71, B:R.75, B:E.197, B:E.197, B:R.212
- Salt bridges: B:R.37, B:R.212, B:R.287
G39.25: 13 residues within 4Å:- Chain C: R.37, E.38, D.70, R.71, W.98, R.144, N.166, E.196, E.197, R.212, N.214, R.287, Y.321
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:W.98, C:N.166, C:E.196
- Hydrogen bonds: C:E.38, C:R.71
- Water bridges: C:R.71, C:R.75, C:R.75, C:N.166, C:E.197
- Salt bridges: C:R.37, C:R.212, C:R.287
G39.40: 13 residues within 4Å:- Chain D: R.37, E.38, D.70, R.71, W.98, R.144, N.166, E.196, E.197, R.212, N.214, R.287, Y.321
15 PLIP interactions:15 interactions with chain D- Hydrophobic interactions: D:W.98, D:N.166, D:E.196
- Hydrogen bonds: D:E.38, D:R.71, D:Y.321
- Water bridges: D:D.70, D:R.71, D:R.75, D:N.166, D:E.197, D:E.197
- Salt bridges: D:R.37, D:R.212, D:R.287
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 2 residues within 4Å:- Chain A: A.5, N.7
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.7
NAG.16: 2 residues within 4Å:- Chain B: A.5, N.7
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.7
NAG.26: 1 residues within 4Å:- Chain C: N.7
No protein-ligand interaction detected (PLIP)NAG.27: 1 residues within 4Å:- Chain C: N.65
1 PLIP interactions:1 interactions with chain C- Water bridges: C:N.65
NAG.28: 2 residues within 4Å:- Chain C: K.3, N.154
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:K.3, C:N.154
- Water bridges: C:Q.227
NAG.41: 1 residues within 4Å:- Chain D: N.7
No protein-ligand interaction detected (PLIP)NAG.42: 1 residues within 4Å:- Chain D: N.65
1 PLIP interactions:1 interactions with chain D- Water bridges: D:N.65
NAG.43: 2 residues within 4Å:- Chain D: K.3, N.154
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:K.3, D:N.154
- Water bridges: D:Q.227
- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 7 residues within 4Å:- Chain A: N.65, G.66, T.67, K.69, S.72, Y.74
- Chain D: R.26
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: I.68, K.69, D.70
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: Y.89, N.90, S.91
- Chain D: E.84
Ligand excluded by PLIPEDO.9: 3 residues within 4Å:- Chain A: K.271, G.273, T.300
Ligand excluded by PLIPEDO.10: 7 residues within 4Å:- Chain A: E.206, S.224, F.225, N.226, E.230, Y.231, Q.232
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: Y.19, L.46, E.47, C.48
- Chain C: N.128, G.129, I.130
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain B: N.65, G.66, T.67, K.69, S.72, Y.74
- Chain C: R.26
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain B: I.68, K.69, D.70
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain B: Y.89, N.90, S.91
- Chain C: E.84
Ligand excluded by PLIPEDO.20: 3 residues within 4Å:- Chain B: K.271, G.273, T.300
Ligand excluded by PLIPEDO.21: 7 residues within 4Å:- Chain B: E.206, S.224, F.225, N.226, E.230, Y.231, Q.232
Ligand excluded by PLIPEDO.22: 7 residues within 4Å:- Chain B: Y.19, L.46, E.47, C.48
- Chain D: N.128, G.129, I.130
Ligand excluded by PLIPEDO.29: 7 residues within 4Å:- Chain A: R.26
- Chain C: N.65, G.66, T.67, K.69, S.72, Y.74
Ligand excluded by PLIPEDO.30: 3 residues within 4Å:- Chain C: I.68, K.69, D.70
Ligand excluded by PLIPEDO.31: 8 residues within 4Å:- Chain A: W.16, A.17, I.18, Q.310, T.371, V.372, W.376
- Chain C: V.124
Ligand excluded by PLIPEDO.32: 3 residues within 4Å:- Chain C: I.182, K.184, S.185
Ligand excluded by PLIPEDO.33: 3 residues within 4Å:- Chain C: E.187, N.189, A.190
Ligand excluded by PLIPEDO.34: 2 residues within 4Å:- Chain C: N.189, P.191
Ligand excluded by PLIPEDO.35: 4 residues within 4Å:- Chain C: D.203, K.271, Y.272, G.273
Ligand excluded by PLIPEDO.36: 6 residues within 4Å:- Chain B: N.128, I.130
- Chain C: Y.19, L.46, E.47, C.48
Ligand excluded by PLIPEDO.44: 7 residues within 4Å:- Chain B: R.26
- Chain D: N.65, G.66, T.67, K.69, S.72, Y.74
Ligand excluded by PLIPEDO.45: 3 residues within 4Å:- Chain D: I.68, K.69, D.70
Ligand excluded by PLIPEDO.46: 8 residues within 4Å:- Chain B: W.16, A.17, I.18, Q.310, T.371, V.372, W.376
- Chain D: V.124
Ligand excluded by PLIPEDO.47: 3 residues within 4Å:- Chain D: I.182, K.184, S.185
Ligand excluded by PLIPEDO.48: 3 residues within 4Å:- Chain D: E.187, N.189, A.190
Ligand excluded by PLIPEDO.49: 2 residues within 4Å:- Chain D: N.189, P.191
Ligand excluded by PLIPEDO.50: 4 residues within 4Å:- Chain D: D.203, K.271, Y.272, G.273
Ligand excluded by PLIPEDO.51: 6 residues within 4Å:- Chain A: N.128, I.130
- Chain D: Y.19, L.46, E.47, C.48
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pokorna, J. et al., Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus. Viruses (2018)
- Release Date
- 2018-07-04
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.69 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 10 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pokorna, J. et al., Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus. Viruses (2018)
- Release Date
- 2018-07-04
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
AD
A